These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6352273)
41. Usefulness of penbutolol for systemic hypertension. Penbutolol Research Group. Schoenberger JA Am J Cardiol; 1989 Jun; 63(18):1339-42. PubMed ID: 2658525 [TBL] [Abstract][Full Text] [Related]
42. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial. Muiesan G; Agabiti-Rosei E; Alicandri C; Motolese M Clin Exp Pharmacol Physiol Suppl; 1978; 4():35-41. PubMed ID: 354827 [TBL] [Abstract][Full Text] [Related]
43. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol. Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155 [TBL] [Abstract][Full Text] [Related]
44. Prorenin and beta-blockade in hypertension. McKenna F; Davison AM Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678 [TBL] [Abstract][Full Text] [Related]
45. [Plasma renin activity and urinary excretion of catecholamines and their metabolites in patients with primary arterial hypertension treated with metoprolol]. Wocial B; Januszewicz W; Sznajderman M; Cybulska I; Brym E; Czerniewska E Pol Tyg Lek; 1983 Apr; 38(14):439-42. PubMed ID: 6356082 [No Abstract] [Full Text] [Related]
46. Effect of the dopamine agonist bromocriptine on blood pressure, catecholamines and renin activity in acromegalics at rest, following exercise and during insulin induced hypoglycemia. Nilsson A; Hökfelt B Acta Endocrinol Suppl (Copenh); 1978; 216():83-96. PubMed ID: 274039 [TBL] [Abstract][Full Text] [Related]
47. Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension. Fritschka E; Gotzen R; Kittler R; Schöneshöfer M Br J Pharmacol; 1984 Feb; 81(2):245-53. PubMed ID: 6367871 [TBL] [Abstract][Full Text] [Related]
48. The effect of naloxone on blood pressure, heart rate, plasma catecholamines, renin activity and aldosterone following exercise in healthy males. Bramnert M Regul Pept; 1988 Sep; 22(4):295-301. PubMed ID: 3055074 [TBL] [Abstract][Full Text] [Related]
49. Penbutolol in hypertension, alone and in combination with furosemide. A long-term multicentre study. Vander Elst E; Lawrence J; Rössner M; Mertens H S Afr Med J; 1983 Jan; 63(5):143-7. PubMed ID: 6336854 [TBL] [Abstract][Full Text] [Related]
50. Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol. Kubik MM; Hanks GW Eur J Clin Pharmacol; 1980 Jun; 17(6):409-13. PubMed ID: 6995132 [TBL] [Abstract][Full Text] [Related]
51. Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans. Venter CP; Joubert PH; Venter HL; Muntingh GL; du Plooy WJ J Clin Pharmacol; 1990 Jun; 30(6):533-7. PubMed ID: 2355104 [TBL] [Abstract][Full Text] [Related]
52. [Effect of penbutolol on the hemodynamics in patients with hypertensive disease]. Demin AA; Mitrokhin VE Farmakol Toksikol; 1986; 49(5):74-6. PubMed ID: 3770181 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function. van der Meulen J; Reijn E; Heidendal GA; Oe PL; Donker AJ Br J Clin Pharmacol; 1986 Oct; 22(4):469-74. PubMed ID: 3533129 [TBL] [Abstract][Full Text] [Related]
54. Effects of beta 1-selective and non-selective beta-blockade on blood pressure, plasma renin activity and plasma aldosterone in hypertensive patients. van Herwaarden CL; Fennis JF; van 'T Laar A Neth J Med; 1979; 22(1):17-22. PubMed ID: 368667 [No Abstract] [Full Text] [Related]
55. Relationship between plasma catecholamines, plasma renin activity, aldosterone, and arterial pressure during postural stress in normal subjects. Campese VM; Romoff M; DeQuattro V; Massry SG J Lab Clin Med; 1980 Jun; 95(6):927-33. PubMed ID: 6991621 [TBL] [Abstract][Full Text] [Related]
57. Single-blind comparison of penbutolol and long-acting propranolol in general practice. Hayes G Pharmatherapeutica; 1983; 3(7):456-63. PubMed ID: 6366804 [TBL] [Abstract][Full Text] [Related]
58. A long-term study of plasma catecholamine levels and plasma renin activity in borderline hypertension. Böhm RO; van Baak MA; van Hooff ME; Mooy J; Rahn KH J Hypertens; 1987 Dec; 5(6):655-61. PubMed ID: 3323317 [TBL] [Abstract][Full Text] [Related]
59. [Validity of the use of penbutolol in essential arterial hypertension]. Pepe S; Scalici G; D'Angelo A; Curiale B; Corrao S; Agnello C Minerva Med; 1990 Jun; 81(6):471-3. PubMed ID: 2359502 [TBL] [Abstract][Full Text] [Related]
60. Penbutolol: comparison of its antihypertensive effect with that of alpha-methyldopa in patients with primary hypertension. Vierhapper H; Dudczak R; Waldhäusl W Arzneimittelforschung; 1980; 30(6):1008-11. PubMed ID: 7191259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]